Loading provider…
Loading provider…
Nephrology Physician in Punta Gorda, FL
NPI: 1003023581Primary Practice Location
Port Charlotte Artificial Kidney Center
4300 Kings Hwy, Punta Gorda, FL
Primary Employer
Charlotte Nephrology Associates PA
HQ Phone
Get Jaideep's Phone Numberphone_androidMobile
Get Jaideep's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMD State Medical License
FL State Medical License
FL State Medical License
2009 - 2027
TX State Medical License
2008 - 2021
MI State Medical License
2007 - 2014

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Nephrology
Good Samaritan Hospital of Maryland
Residency • Internal Medicine
2004 - 2007
Topiwala National Medical College
Medical School
Until 1995
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 474 | 990 |
| 2 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 237 | 775 |
| 3 | 99223Initial hospital inpatient care, typically 70 minutes per day | 209 | 246 |
| 4 | 99213Established patient office or other outpatient visit, typically 15 minutes | 112 | 161 |
| 5 | 99203New patient outpatient visit, total time 30-44 minutes | 84 | 84 |
Fibrillary glomerulonephritis in a patient with systemic lupus erythematosus: a rare association.
Authors: Zeenat Bhat, Salman Khan, Xu Zeng, Madhumita Mohanty
Journal: Int Urol Nephrol
Publication Date: 2011-11-19
Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Intervention / Treatment: DIAGNOSTIC_TEST: DetermaRX
Lead Sponsor: Riphah International University
Intervention / Treatment: OTHER: Pilates Exercise - Online, OTHER: Pilates Exercise - Supervised
Lead Sponsor: Novartis Pharmaceuticals
Intervention / Treatment: DRUG: Enzalutamide, DRUG: Abiraterone, DRUG: JSB462